Navann Ty
Stock Analyst at Exane BNP Paribas
(3.25)
# 2,369
Out of 4,386 analysts
39
Total ratings
55.6%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Navann Ty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OGN Organon & Co. | Downgraded: Hold | $15 → $14 | $13.39 | +4.56% | 6 | Apr 28, 2026 | |
| MDLN Medline | Initiated Coverage: Hold | $38 | $33.80 | +12.43% | 1 | Jan 12, 2026 | |
| NTRA Natera | Upgraded: Hold | $28 → $172 | $213.47 | -19.43% | 2 | Oct 27, 2025 | |
| GEHC GE HealthCare Technologies | Reiterated: Buy | $92 | $64.67 | +42.26% | 1 | Sep 10, 2025 | |
| PAHC Phibro Animal Health | Maintained: Hold | $24 → $37 | $31.76 | +16.50% | 2 | Sep 4, 2025 | |
| COO The Cooper Companies | Upgraded: Buy | $92 | $66.79 | +37.75% | 1 | Jul 22, 2025 | |
| KVUE Kenvue | Initiated Coverage: Hold | $28 | $17.55 | n/a | 1 | May 30, 2023 | |
| SKIN SkinHealth Systems | Upgraded: Hold | n/a | $0.6341 | n/a | 2 | Mar 20, 2023 | |
| ABBV AbbVie | Initiated Coverage: Hold | $169 | $223.07 | n/a | 1 | Dec 8, 2022 | |
| EOLS Evolus | Initiated Coverage: Buy | $13 | $6.68 | n/a | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $26 | $42.45 | n/a | 2 | Mar 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $11 | $15.93 | n/a | 2 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $232 → $208 | $78.82 | n/a | 6 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $200 | $232.04 | n/a | 1 | Oct 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $39 → $42 | $23.68 | n/a | 6 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36.26 → $51.60 | $7.16 | n/a | 3 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 | $33.26 | n/a | 1 | Apr 24, 2020 |
Organon & Co.
Apr 28, 2026
Downgraded: Hold
Price Target: $15 → $14
Current: $13.39
Upside: +4.56%
Medline
Jan 12, 2026
Initiated Coverage: Hold
Price Target: $38
Current: $33.80
Upside: +12.43%
Natera
Oct 27, 2025
Upgraded: Hold
Price Target: $28 → $172
Current: $213.47
Upside: -19.43%
GE HealthCare Technologies
Sep 10, 2025
Reiterated: Buy
Price Target: $92
Current: $64.67
Upside: +42.26%
Phibro Animal Health
Sep 4, 2025
Maintained: Hold
Price Target: $24 → $37
Current: $31.76
Upside: +16.50%
The Cooper Companies
Jul 22, 2025
Upgraded: Buy
Price Target: $92
Current: $66.79
Upside: +37.75%
Kenvue
May 30, 2023
Initiated Coverage: Hold
Price Target: $28
Current: $17.55
Upside: n/a
SkinHealth Systems
Mar 20, 2023
Upgraded: Hold
Price Target: n/a
Current: $0.6341
Upside: n/a
AbbVie
Dec 8, 2022
Initiated Coverage: Hold
Price Target: $169
Current: $223.07
Upside: n/a
Evolus
Dec 8, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $6.68
Upside: n/a
Mar 22, 2022
Maintained: Hold
Price Target: $22 → $26
Current: $42.45
Upside: n/a
Mar 10, 2022
Maintained: Hold
Price Target: $16 → $11
Current: $15.93
Upside: n/a
Mar 9, 2022
Maintained: Hold
Price Target: $232 → $208
Current: $78.82
Upside: n/a
Oct 5, 2021
Initiated Coverage: Buy
Price Target: $200
Current: $232.04
Upside: n/a
May 17, 2021
Maintained: Buy
Price Target: $39 → $42
Current: $23.68
Upside: n/a
Mar 2, 2021
Maintained: Buy
Price Target: $36.26 → $51.60
Current: $7.16
Upside: n/a
Apr 24, 2020
Initiated Coverage: Hold
Price Target: $10
Current: $33.26
Upside: n/a